HS GovTech Solutions Inc.
HS GovTech Solutions Inc. HS.CN Peers
See (HS.CN) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HS.CN | CA$0.53 | +3.92% | 29M | -3.31 | -CA$0.16 | N/A |
| KSI.TO | CA$6.65 | +0.76% | 627.7M | -221.67 | -CA$0.03 | N/A |
| VHI.TO | CA$11.00 | -1.96% | 593.9M | 275.00 | CA$0.04 | N/A |
| CARE.TO | CA$5.15 | +0.10% | 345.7M | -17.15 | -CA$0.30 | N/A |
| TRUE.CN | CA$0.38 | -1.30% | 22M | -2.00 | -CA$0.19 | N/A |
| UDOC.CN | CA$0.28 | +10.00% | 21M | -3.06 | -CA$0.09 | N/A |
| AIML.CN | CA$0.09 | N/A | 14.7M | -1.42 | -CA$0.06 | N/A |
| RYAH.CN | CA$0.03 | N/A | 11.2M | -0.15 | -CA$0.17 | N/A |
| TELE.CN | CA$0.09 | N/A | 7.6M | -0.13 | -CA$0.69 | N/A |
| LYNX.CN | CA$0.06 | N/A | 6.4M | -0.29 | -CA$0.21 | N/A |
Stock Comparison
HS.CN vs KSI.TO Comparison
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, KSI.TO has a market cap of 627.7M. Regarding current trading prices, HS.CN is priced at CA$0.53, while KSI.TO trades at CA$6.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas KSI.TO's P/E ratio is -221.67. In terms of profitability, HS.CN's ROE is -1.34%, compared to KSI.TO's ROE of -0.05%. Regarding short-term risk, HS.CN is more volatile compared to KSI.TO. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.
HS.CN vs VHI.TO Comparison
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, VHI.TO has a market cap of 593.9M. Regarding current trading prices, HS.CN is priced at CA$0.53, while VHI.TO trades at CA$11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas VHI.TO's P/E ratio is 275.00. In terms of profitability, HS.CN's ROE is -1.34%, compared to VHI.TO's ROE of +0.02%. Regarding short-term risk, HS.CN is more volatile compared to VHI.TO. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.
HS.CN vs CARE.TO Comparison
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, CARE.TO has a market cap of 345.7M. Regarding current trading prices, HS.CN is priced at CA$0.53, while CARE.TO trades at CA$5.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas CARE.TO's P/E ratio is -17.15. In terms of profitability, HS.CN's ROE is -1.34%, compared to CARE.TO's ROE of -0.23%. Regarding short-term risk, HS.CN is more volatile compared to CARE.TO. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.
HS.CN vs TRUE.CN Comparison
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, TRUE.CN has a market cap of 22M. Regarding current trading prices, HS.CN is priced at CA$0.53, while TRUE.CN trades at CA$0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas TRUE.CN's P/E ratio is -2.00. In terms of profitability, HS.CN's ROE is -1.34%, compared to TRUE.CN's ROE of -11.21%. Regarding short-term risk, HS.CN is less volatile compared to TRUE.CN. This indicates potentially lower risk in terms of short-term price fluctuations for HS.CN.
HS.CN vs UDOC.CN Comparison
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, UDOC.CN has a market cap of 21M. Regarding current trading prices, HS.CN is priced at CA$0.53, while UDOC.CN trades at CA$0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas UDOC.CN's P/E ratio is -3.06. In terms of profitability, HS.CN's ROE is -1.34%, compared to UDOC.CN's ROE of +6.57%. Regarding short-term risk, HS.CN is less volatile compared to UDOC.CN. This indicates potentially lower risk in terms of short-term price fluctuations for HS.CN.
HS.CN vs AIML.CN Comparison
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, AIML.CN has a market cap of 14.7M. Regarding current trading prices, HS.CN is priced at CA$0.53, while AIML.CN trades at CA$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas AIML.CN's P/E ratio is -1.42. In terms of profitability, HS.CN's ROE is -1.34%, compared to AIML.CN's ROE of -11.81%. Regarding short-term risk, HS.CN is more volatile compared to AIML.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.
HS.CN vs RYAH.CN Comparison
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, RYAH.CN has a market cap of 11.2M. Regarding current trading prices, HS.CN is priced at CA$0.53, while RYAH.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas RYAH.CN's P/E ratio is -0.15. In terms of profitability, HS.CN's ROE is -1.34%, compared to RYAH.CN's ROE of +14.95%. Regarding short-term risk, HS.CN is more volatile compared to RYAH.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.
HS.CN vs TELE.CN Comparison
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, TELE.CN has a market cap of 7.6M. Regarding current trading prices, HS.CN is priced at CA$0.53, while TELE.CN trades at CA$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas TELE.CN's P/E ratio is -0.13. In terms of profitability, HS.CN's ROE is -1.34%, compared to TELE.CN's ROE of +0.00%. Regarding short-term risk, HS.CN is more volatile compared to TELE.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.
HS.CN vs LYNX.CN Comparison
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, LYNX.CN has a market cap of 6.4M. Regarding current trading prices, HS.CN is priced at CA$0.53, while LYNX.CN trades at CA$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas LYNX.CN's P/E ratio is -0.29. In terms of profitability, HS.CN's ROE is -1.34%, compared to LYNX.CN's ROE of +0.00%. Regarding short-term risk, HS.CN is more volatile compared to LYNX.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.
HS.CN vs NARA.CN Comparison
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, NARA.CN has a market cap of 5.2M. Regarding current trading prices, HS.CN is priced at CA$0.53, while NARA.CN trades at CA$0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas NARA.CN's P/E ratio is -0.07. In terms of profitability, HS.CN's ROE is -1.34%, compared to NARA.CN's ROE of +1.85%. Regarding short-term risk, HS.CN is more volatile compared to NARA.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.
HS.CN vs DMED.CN Comparison
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, DMED.CN has a market cap of 3.3M. Regarding current trading prices, HS.CN is priced at CA$0.53, while DMED.CN trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas DMED.CN's P/E ratio is -4.00. In terms of profitability, HS.CN's ROE is -1.34%, compared to DMED.CN's ROE of +5.62%. Regarding short-term risk, HS.CN is more volatile compared to DMED.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.
HS.CN vs LITE.CN Comparison
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, LITE.CN has a market cap of 2M. Regarding current trading prices, HS.CN is priced at CA$0.53, while LITE.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas LITE.CN's P/E ratio is -0.50. In terms of profitability, HS.CN's ROE is -1.34%, compared to LITE.CN's ROE of -6.63%. Regarding short-term risk, HS.CN is more volatile compared to LITE.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.
HS.CN vs CBP.CN Comparison
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, CBP.CN has a market cap of 1.7M. Regarding current trading prices, HS.CN is priced at CA$0.53, while CBP.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas CBP.CN's P/E ratio is -1.00. In terms of profitability, HS.CN's ROE is -1.34%, compared to CBP.CN's ROE of +0.08%. Regarding short-term risk, HS.CN is more volatile compared to CBP.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.
HS.CN vs TMED.CN Comparison
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, TMED.CN has a market cap of 1.5M. Regarding current trading prices, HS.CN is priced at CA$0.53, while TMED.CN trades at CA$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas TMED.CN's P/E ratio is -6.50. In terms of profitability, HS.CN's ROE is -1.34%, compared to TMED.CN's ROE of +0.29%. Regarding short-term risk, HS.CN is more volatile compared to TMED.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.
HS.CN vs CGN.CN Comparison
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, CGN.CN has a market cap of 895.9K. Regarding current trading prices, HS.CN is priced at CA$0.53, while CGN.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas CGN.CN's P/E ratio is -0.13. In terms of profitability, HS.CN's ROE is -1.34%, compared to CGN.CN's ROE of +0.96%. Regarding short-term risk, HS.CN is more volatile compared to CGN.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.
HS.CN vs NDAT.CN Comparison
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, NDAT.CN has a market cap of 619.9K. Regarding current trading prices, HS.CN is priced at CA$0.53, while NDAT.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas NDAT.CN's P/E ratio is -0.75. In terms of profitability, HS.CN's ROE is -1.34%, compared to NDAT.CN's ROE of -0.62%. Regarding short-term risk, HS.CN is more volatile compared to NDAT.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.
HS.CN vs KETA.CN Comparison
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, KETA.CN has a market cap of 266.3K. Regarding current trading prices, HS.CN is priced at CA$0.53, while KETA.CN trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas KETA.CN's P/E ratio is -1.00. In terms of profitability, HS.CN's ROE is -1.34%, compared to KETA.CN's ROE of +0.33%. Regarding short-term risk, HS.CN is more volatile compared to KETA.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.
HS.CN vs MEND.CN Comparison
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, MEND.CN has a market cap of 0. Regarding current trading prices, HS.CN is priced at CA$0.53, while MEND.CN trades at CA$0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas MEND.CN's P/E ratio is N/A. In terms of profitability, HS.CN's ROE is -1.34%, compared to MEND.CN's ROE of -1.68%. Regarding short-term risk, HS.CN is more volatile compared to MEND.CN. This indicates potentially higher risk in terms of short-term price fluctuations for HS.CN.
HS.CN vs WTEQ.CN Comparison
HS.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HS.CN stands at 29M. In comparison, WTEQ.CN has a market cap of 0. Regarding current trading prices, HS.CN is priced at CA$0.53, while WTEQ.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HS.CN currently has a P/E ratio of -3.31, whereas WTEQ.CN's P/E ratio is 2.00. In terms of profitability, HS.CN's ROE is -1.34%, compared to WTEQ.CN's ROE of -1.70%. Regarding short-term risk, Volatility data is not available for a full comparison. HS.CN has daily volatility of 3.85 and WTEQ.CN has daily volatility of N/A.